Evidence map›Paper›PMID 32848935›Full record

ArticleFrontiers in psychiatry2020

Remission from Chronic Anorexia Nervosa With Ketogenic Diet and Ketamine: Case Report.

Barbara Scolnick, Beth Zupec-Kania, Lori Calabrese, Chiye Aoki, Thomas Hildebrandt

2 registry-linked trialsOpen access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06000774 narecruitingnot on this mapstarted 2023, after this paper: background citation

Ketogenic Diet in Eating Disorders to Target Metabolism and Normalize Persistent Eating Disorder Psychopathology

TypeinterventionalSponsorUniversity of California, San DiegoRan2023 to 2027Enrolled20ConditionsAnorexia Nervosa in Remission, Bulimia Nervosa, Anorexia NervosaArmsTherapeutic Ketogenic Diet
NCT06605027 nawithdrawnnot on this mapstarted 2027, after this paper: background citation

Therapeutic Ketogenic Diet to Treat Anorexia Nervosa-Specific Cognitions and Behaviors - Currently Ill Individuals in PHP Level of Care and Comparison With Standard of Care

TypeinterventionalSponsorUniversity of California, San DiegoRan2027 to 2028Enrolled0ConditionsAnorexia NervosaArmsTherapeutic Ketogenic Diet
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Barbara ScolnickInternal Medicine & Addiction Medicine, Waban, MA, United States.
Beth Zupec-KaniaConsultant-Ketogenic Diet Therapy LLC, Elm Grove, WI, United States.
Lori CalabreseInnovative Psychiatry, South Windsor, CT, United States.
Chiye AokiCenter for Neural Sciences, New York University, New York, NY, United States.
Thomas HildebrandtCenter of Excellence in Eating and Weight Disorders, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
American Society of Addiction Medicine · USIcahn School of Medicine at Mount Sinai · USInnovative Clinical Research · USNew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic anorexia nervosa is a tragic disease with no known effective pharmacological or behavioral treatment. We report the case of a 29 year-old woman who struggled with severe and enduring anorexia nervosa for 15 years, and experienced a complete recovery following a novel treatment of adopting a ketogenic diet followed by ketamine infusions. Her remission has persisted for over 6 months. CASE PRESENTATION: At age 14.5, the patient embarked on an effort to "eat healthy." She quickly lost control of the dieting, developed associated compulsions and obsessions about food, body dissatisfaction, emotional lability, and lost nearly 13.6 kilograms (30 pounds). She was hospitalized for 6 weeks, and while she regained some weight, she did not attain full weight restoration. For 15 years, she continued to eat in a restrictive manner, exercise compulsively, and have intermittent periods of alcohol dependence. Nevertheless, she always hoped to get well, and at age 29, she began a novel treatment for anorexia nervosa.

conclusionsThis is the first report of a ketogenic diet used specifically for the treatment of anorexia nervosa, followed by a short series of titrated IV ketamine infusions leading to complete remission of severe and enduring anorexia nervosa, with weight restoration, and sustained cessation of cognitive and behavioral symptoms, for 6 months. Although these treatments were used sequentially the relationship between these modalities, and possible synergy, is unclear, and deserves further study. Complete and sustained remission of chronic anorexia nervosa is quite rare, and the novel use of a ketogenic diet and IV ketamine treatment in this potentially lethal condition suggests avenues for further research, and hope for patients and their families.

Indexed as

activity-based-anorexia animal modelanorexia nervosabrain-derived-neurotrophic factor (BDNF)ketamineketogenic diet

Identifiers

PMID32848935
PMCPMC7412264
OpenAlexW3045557596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.